Nisa Investment Advisors
TARS icon

Nisa Investment Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Nisa Investment Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Buy
505
+102
+25% +$6.52K ﹤0.01% 2032
2026
Q1 		$28.3K Sell
403
-3
-0.7% -$210 ﹤0.01% 1889
2025
Q4 		$33.2K Sell
406
-51
-11% -$3.81K ﹤0.01% 1754
2025
Q3 		$27.2K Hold
457
– – ﹤0.01% 1856
2025
Q2 		$18.5K Hold
457
– – ﹤0.01% 1979
2025
Q1 		$23.5K Buy
457
+308
+207% +$15.2K ﹤0.01% 1817
2024
Q4 		$8.25K Buy
149
+49
+49% +$2.23K ﹤0.01% 2175
2024
Q3 		$3.29K Buy
100
+35
+54% +$984 ﹤0.01% 2307
2024
Q2 		$1.77K Buy
65
+24
+59% +$807 ﹤0.01% 2394
2024
Q1 		$1.49K Buy
41
+31
+310% +$911 ﹤0.01% 2285
2023
Q4 		$203 Sell
10
-15
-60% -$250 ﹤0.01% 2555
2023
Q3 		$444 Buy
25
+10
+67% +$177 ﹤0.01% 2548
2023
Q2 		$271 Buy
+15
New +$238 ﹤0.01% 2674

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nisa Investment Advisors's TARS Position: Q2 2026 in Review

Nisa Investment Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 25% in Q2 2026, buying an estimated $6.52K and bringing the position to 505 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Nisa Investment Advisors first reported a position in TARS in Q2 2023 and has held it in 13 quarters since. The position peaked at $33.2K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Nisa Investment Advisors held 505 shares of Tarsus Pharmaceuticals worth $31.8K as of Q2 2026.
  • Nisa Investment Advisors bought 102 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $6.52K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2032 holding.
  • Nisa Investment Advisors first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Nisa Investment Advisors's Tarsus Pharmaceuticals position peaked at $33.2K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.